Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes
about
Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein InterfaceCreating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug designCombinatorial tuning of peptidic drug candidates: high-affinity matriptase inhibitors through incremental structure-guided optimization.Ligand-induced protein mobility in complexes of carbonic anhydrase II and benzenesulfonamides with oligoglycine chainsA fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.Novel 2-aminobenzamides as potential orally active antithrombotic agents.Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases.Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.Protein-Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background-Free Amidation Reaction.Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA-Encoded Self-Assembling Chemical Libraries.Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.Pairwise binding competition experiments for sorting hub-protein/effector interaction hierarchy and simultaneous equilibria
P2860
Q27674729-D4B40982-E378-4858-9430-6B24A754BCA8Q28543133-4D2649CD-FE6D-40B5-9F07-AAD3A998856AQ34567179-99042212-D62E-4AD4-91F7-AADE42FDDF7FQ34614404-E2AFCDB1-34DF-4B9B-838E-E0D0ED8AECFAQ38557670-EDFD9435-1115-4424-9362-2ACD48DF0580Q39781030-5EC6A64D-A09D-41FA-82B8-DDCA36BC0960Q40254260-6421960F-E051-4700-B4D4-79A7E416BCF6Q41109181-B8978FED-388C-4085-8034-FF72B7CC56D2Q42314613-B95B9701-7C99-4022-98C5-4D600D960CCEQ47750102-A4B8CE83-895A-4DD2-930C-14D7130DAA43Q52970803-B8D225DD-64B8-4D18-B6DA-6EFF6150345EQ58620912-D2DDAFF3-509D-47A0-B99B-A32D46F3EF1B
P2860
Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@ast
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@en
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@nl
type
label
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@ast
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@en
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@nl
prefLabel
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@ast
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@en
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@nl
P2093
P2860
P356
P1476
Fragment deconstruction of sma ...... ng in protein-ligand complexes
@en
P2093
Armin Bauer
David W Will
Hans Matter
Jörg Czech
Kurt Ritter
Matthias Urmann
Michael Wagner
Volkmar Wehner
P2860
P304
P356
10.1002/ANIE.201107091
P407
P577
2011-12-21T00:00:00Z